Dr. Daphne Koller of insitro on Digital Biology and Drug Discovery

This is the last episode of Season 1. Join us in the Fall for Season 2, and in the meantime, please take our brief survey! http://bit.ly/theaihealthpodcast Dr. Daphne Koller is CEO and Founder of insitro, a machine-learning enabled drug discovery company. She has been a Stanford CS Professor, co-founder of Coursera and Engageli, one of TIME Magazine’s 100 influential people, and a MacArthur Fellow. She speaks with us about how insitro uses AI and induced pluripotent stem cells to make drug discovery more efficient and successful. Pranav and Adriel first give an overview on pluripotent stem cells. The interview with Dr. Koller starts at 5:41. If you like what you hear, let a friend know, subscribe wherever you get your podcasts, and connect with us on Twitter @AIHealthPodcast.

Om Podcasten

Explore the ways in which AI will transform healthcare, biotech, and medicine through conversations with entrepreneurs, investors and scientists. Hosted by Pranav Rajpurkar and Adriel Saporta. Produced by Oishi Banerjee and Marc Robbins.